(Q43778219)

26 November 2017

title

Prescribing propensity: influence of life-expectancy gains and drug costs (English)

1 reference

26 November 2017

J E Hux

1

1 reference

26 November 2017

C M Levinton

series ordinal

2

1 reference

26 November 2017

C D Naylor

series ordinal

3

1 reference

26 November 2017

publication date

1 April 1994

1 reference

Journal of General Internal Medicine

26 November 2017

published in

1 reference

26 November 2017

volume

9

1 reference

26 November 2017

issue

4

1 reference

26 November 2017

page(s)

195-201

1 reference

Cholesterol reduction and life expectancy. A model incorporating multiple risk factors

26 November 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02600123

Fallacy of the five-year survival in lung cancer

21 January 2018

1 reference

12 December 2020

Ego bias, reverse ego bias, and physicians' prognostic

1 reference

12 December 2020

Choosing between apples and apples: physicians' choices of prescription drugs that have similar side effects and efficacies

1 reference

12 December 2020

Absolutely relative: how research results are summarized can affect treatment decisions

1 reference

12 December 2020

Measured enthusiasm: does the method of reporting trial results alter perceptions of therapeutic effectiveness?

1 reference

12 December 2020

Optimistic biases about personal risks

1 reference

12 December 2020

The benefits of treating hyperlipidemia to prevent coronary heart disease. Estimating changes in life expectancy and morbidity

1 reference

12 December 2020

Discrepancy between medical decisions for individual patients and for groups

1 reference

12 December 2020

On the elicitation of preferences for alternative therapies.

1 reference

12 December 2020

Cholesterol lowering and mortality: the importance of considering initial level of risk

1 reference

12 December 2020

Judgment under Uncertainty: Heuristics and Biases

1 reference

12 December 2020

The framing of decisions and the psychology of choice

1 reference

12 December 2020

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

12 December 2020

Can physician education lower the cost of prescription drugs? A prospective, controlled trial

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02600123

1 reference

Dimensions Publication ID

26 November 2017

1021481107

0 references

1 reference